FNP-223 - Ferrer International
O-linked N-acetylglucosaminidase - Summit Therapeutics
https://www.mdsabstracts.org/abstract/safety-tolerability-and-pharmacokinetics-of-a-novel-oral-oga-inhibitor-fnp-223-first-in-human-phase-1-study/
 
R. Pokorny; J M. Ryan; K. Abd-Elaziz; C. Varona; M. Schneider; C. Wiessner; J F. Stallaert; B. Permanne; A. Quattropani; D. Beher
 
Oct 16, 2025
 
Prev Next